Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Establishment Labs Holdings's enterprise value is $2,906.4 Mil.
Establishment Labs Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-14.2 Mil. Therefore, Establishment Labs Holdings's EV-to-EBITDA for today is -204.26.
The historical rank and industry rank for Establishment Labs Holdings's EV-to-EBITDA or its related term are showing as below:
ESTA'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -241.89 Med: -30.5 Max: -6.8
Current: -204.26
During the past 10 years, the highest EV-to-EBITDA of Establishment Labs Holdings was -6.80. The lowest was -241.89. And the median was -30.50.
ESTA's EV-to-EBITDA is ranked worse than 100% of 510
companies
in the Medical Devices & Instruments industry
Industry Median: 14.115
vs ESTA: -204.26
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Establishment Labs Holdings's PE Ratio (TTM) for today is calculated as:
Establishment Labs Holdings's share price for today is $92.07.
Establishment Labs Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.490.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Establishment Labs Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Establishment Labs Holdings EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Establishment Labs Holdings's EV-to-EBITDA falls into.
Establishment Labs Holdings's current Enterprise Value is $2,906.4 Mil.
Establishment Labs Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Establishment Labs Holdings (ESTA) has a EV-to-EBITDA of -204.26 as of Jul. 28, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Establishment Labs Holdings. According to the industry distribution chart, Establishment Labs Holdings ranks #999999 out of 510 companies in the Medical Devices & Instruments industry.
Is Establishment Labs Holdings' EV-to-EBITDA too high?
Establishment Labs Holdings' current EV-to-EBITDA is -204.26. Based on the distribution chart, Establishment Labs Holdings ranks #999999 out of 510 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Establishment Labs Holdings has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Establishment Labs Holdings' EV-to-EBITDA compare to TMDX and AXGN?
According to the Medical Devices & Instruments industry distribution chart, Establishment Labs Holdings ranks #999999 out of 510 companies for EV-to-EBITDA. This places Establishment Labs Holdings in the lower half of its industry. The industry median EV-to-EBITDA is 14.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.12, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Establishment Labs Holdings. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Establishment Labs Holdings's current EV-to-EBITDA is -204.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Establishment Labs Holdings stock overvalued right now?
Based on GuruFocus' analysis, Establishment Labs Holdings (ESTA) is currently considered Significantly Overvalued. The stock's GF Value™ is $62.39, compared to a current price of $92.07 — trading 47.6% above its estimated fair value. The current EV-to-EBITDA is -204.26. Establishment Labs Holdings' overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Establishment Labs Holdings (ESTA), the current EV-to-EBITDA is -204.26 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Establishment Labs Holdings (ESTA) Overvalued in 2026?
Based on GuruFocus' analysis, Establishment Labs Holdings stock appears to be overvalued.
The current stock price of $92.07 is trading 47.6% above its estimated GF Value™ of $62.39.
GuruFocus considers Establishment Labs Holdings to be Significantly Overvalued.
Key valuation signals for ESTA:
EV-to-EBITDA: -204.26
GF Value™: $62.39 vs. price of $92.07 (47.6% above fair value)
No single metric tells the full story. See the ESTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
69GF Score
Get the complete analysis for ESTA
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESTA has been successfully added to your 
